Back to Blog

Supplements That Reduce Inflammation Biomarkers: CRP, IL-6, TNF

February 26, 2026·5 min read

Chronic low-grade inflammation, measured by biomarkers like high-sensitivity CRP (hsCRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and fibrinogen, is now recognized as a central mechanism driving cardiovascular disease, neurodegeneration, metabolic disease, and cancer. Unlike acute inflammation (which is necessary for healing), chronic systemic inflammation operates below the threshold of symptoms while silently accelerating tissue damage. These supplements have randomized controlled trial evidence for reducing these specific biomarkers.

High-Sensitivity CRP: The Marker to Watch

hsCRP is the most practical and widely available inflammation biomarker. Values below 1 mg/L are optimal; above 3 mg/L represents high cardiovascular risk. Elevated hsCRP predicts future cardiac events better than LDL cholesterol in some populations. Before spending on longevity supplements, getting a baseline hsCRP is one of the most actionable diagnostic steps available.

Omega-3 Fatty Acids (EPA and DHA)

Omega-3s are among the most consistent anti-inflammatory nutrients in the literature. EPA and DHA are converted to resolvins, protectins, and maresins, specialized pro-resolving mediators (SPMs) that actively terminate inflammatory signaling. They also compete with arachidonic acid for cyclooxygenase and lipoxygenase enzymes, reducing eicosanoid inflammatory signaling.

A meta-analysis in PLOS ONE (2017) pooled 68 RCTs and found omega-3 supplementation significantly reduced CRP, IL-6, and TNF-alpha. The effect is dose-dependent. For anti-inflammatory effects: 2 to 4g EPA + DHA daily. Standard cardiovascular doses (1g) show modest effects; higher doses show stronger inflammation reduction.

Curcumin (with Enhanced Bioavailability)

Curcumin from turmeric is one of the most studied anti-inflammatory compounds in natural medicine. It inhibits NF-kB (the master transcription factor for inflammatory gene expression), directly reduces IL-6, TNF-alpha, and IL-1beta synthesis, and inhibits COX-2 (the enzyme targeted by ibuprofen).

The limitation is poor bioavailability. Standard curcumin powder has less than 1% oral bioavailability. Formulations that solve this are essential:

  • Curcumin with piperine (black pepper extract, 20mg per 1g curcumin): increases bioavailability 2,000%
  • Theracurmin (colloidal curcumin): 27x more bioavailable than standard
  • Longvida (solid lipid particles): 65x more bioavailable
  • BCM-95 (complexed with essential oils): 6 to 7x more bioavailable

A meta-analysis in Nutrition Journal (2016) found curcumin significantly reduced CRP and IL-6 in chronic inflammation conditions when bioavailable forms were used.

Dose: 500 to 1,000mg with piperine or a bioavailable form. Standard curcumin powder without piperine is not worth taking.

Magnesium

Magnesium deficiency is strongly associated with elevated CRP and inflammatory markers. This is because intracellular magnesium suppresses NF-kB activation and regulates calcium channel-mediated inflammatory cell signaling. Replenishing magnesium in deficient individuals reliably reduces CRP.

A meta-analysis in European Journal of Clinical Nutrition (2018) found magnesium supplementation significantly reduced CRP levels, particularly in individuals who were deficient or overweight.

Dose: 300 to 400mg magnesium glycinate daily.

Vitamin D

Vitamin D acts as a potent immunomodulatory hormone. Vitamin D receptors on immune cells regulate cytokine production, and deficiency is associated with elevated CRP, IL-6, and TNF-alpha. Correcting deficiency reduces these markers.

A meta-analysis in European Journal of Nutrition (2014) found vitamin D supplementation significantly reduced CRP, particularly in deficient individuals. The effect is largest when correcting from deficiency; already-replete individuals show smaller effects.

Dose: 2,000 to 5,000 IU daily. Combine with K2 (100 to 200mcg MK-7) for optimal distribution.

Quercetin

Quercetin is a flavonoid with powerful NF-kB inhibitory properties. It also inhibits NLRP3 inflammasome activation, a key driver of chronic inflammatory conditions including gout, atherosclerosis, and type 2 diabetes.

A 2017 meta-analysis in Nutrients found quercetin supplementation significantly reduced CRP and TNF-alpha. The bioavailability-enhanced form (quercetin phytosome) is preferable.

Dose: 500 to 1,000mg quercetin phytosome or quercetin with bromelain daily.

Resveratrol

Resveratrol inhibits NF-kB, activates SIRT1, and reduces prostaglandin synthesis. A meta-analysis in Pharmacological Research (2015) found resveratrol supplementation significantly reduced CRP, TNF-alpha, and IL-6 in subjects with metabolic disorders.

Dose: 250 to 500mg daily. Bioavailability is limited; pairing with piperine or using pterostilbene improves this.

FAQ

Q: How long before supplements reduce my CRP? A: Omega-3s show CRP reduction at 8 to 12 weeks. Curcumin and magnesium may show effects in 4 to 8 weeks. Vitamin D correction may take 8 to 16 weeks depending on starting deficiency.

Q: Can I take curcumin every day? A: Yes, at standard bioavailable doses it is safe for long-term daily use. At very high doses (above 8g turmeric extract daily), there are rare reports of liver stress. Stick to evidence-based doses of 500 to 2,000mg bioavailable curcumin.

Q: Which is more important: lowering inflammation or testing for it first? A: Test first. hsCRP, fibrinogen, and omega-3 index tests cost under $100 combined and tell you exactly where you stand. Supplementing without a baseline prevents you from measuring whether your interventions are working.

Related Articles

Track your supplements in Optimize.

Want to optimize your health?

Create your free account and start tracking what matters.

Sign Up Free